Ben Matys, Sr. Clinical Trial Manager, and Ramin Farzaneh-Far, Chief Medical Officer of Ra Pharma, joined Myositis Support and Understanding (MSU) on Wednesday, November 6, 2019, for a live webinar, “Introduction to Ra Pharma & the Potential of Zilucoplan for the Treatment of Immune-Mediated Necrotizing Myopathy (IMNM)”
This video (above) with discussion provides a great overview of IMNM and the complement pathway, information about the Phase 2 Study including locations, with a travel assistance program, and a Q&A session.
